GEA
ACH

Glen Eagle Advisors’s Accendra Health ACH Stock Holding History

Glen Eagle Advisors’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200
Closed -$5.84K – 667
2017
Q3 		$5.84K Hold
200
– – 0.01% 504
2017
Q2 		$6.44K Hold
200
– – 0.01% 455
2017
Q1 		$6.92K Hold
200
– – 0.01% 423
2016
Q4 		$7.06K Buy
+200
New +$6.76K 0.01% 403

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Glen Eagle Advisors's ACH Position: Q4 2017 in Review

Glen Eagle Advisors sold out of Accendra Health (ACH) in Q4 2017, closing a stake of 200 shares — an estimated $5.84K sold.

Glen Eagle Advisors first reported a position in ACH in Q4 2016 and held it in 4 quarters. The position peaked at $7.06K in Q4 2016. 230 funds tracked by Wall St. Rank hold ACH as of Q4 2017.

  • Glen Eagle Advisors reported no remaining Accendra Health position as of Q4 2017 after selling out during the quarter.
  • Glen Eagle Advisors sold 200 Accendra Health shares in Q4 2017, an estimated $5.84K.
  • Glen Eagle Advisors first reported a position in Accendra Health in Q4 2016 and held it in 4 quarters.
  • Glen Eagle Advisors's Accendra Health position peaked at $7.06K in Q4 2016.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q4 2017.

Based on Glen Eagle Advisors's 13F filing for Q4 2017, filed 13 Aug 2024.